LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cell Cycle Assay with Staining Reagents

By Biotechdaily staff writers
Posted on 01 Dec 2004
Cell cycle analysis is easier with a new assay that includes precombined staining regents, eliminating the need for complex reagent preparation following cell fixation.

The assay allows fast and easy examination of cell division phases in immunology, cancer drug discovery, and cell health profiling. Called Cell Cycle, the assay provides detailed protocols for use with either individual tubes or nine-well microtiter plates, thus minimizing assay development time. The automated analysis capability displays results in both histogram and statistical formats. The assay was developed by Guava Technologies, Inc. (Hayward, CA, USA).

The assay uses the nuclear DNA stain propidium iodide (PI) to directly discriminate cells at different stages of the cell cycle. Incubation can be as short as only one hour. Accuracy and high user-to-user reproducibility of absolute cell counts are obtained directly as a standard feature without the need for reference beads.

"Cells in different stages of cell cycle express different genes and proteins. Hence, in addition to determining viability and apoptotic cell fractions, every experiment involving cell populations should be normalized for cell cycle,” explained Kim Mulcahy, director of product marketing at Guava Technologies.





Related Links:
Guava Technologies

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
All-in-One Molecular System
AIO M160
Immunofluorescence Analyzer
IFA System

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
01 Dec 2004  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
01 Dec 2004  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
01 Dec 2004  |   BioResearch